Internal Medicine, Cardiovascular Disease · Springfield, MO
NPI
1417991894
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3800 S National Ave
Springfield, MO, 65807
Phone (417) 875-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$142K
4,247 services
Medicare patients, 2024
1,679
Average age 76
Drug cost, 2024
$3.1M
22,395 prescriptions
Company payments, 2025
$1,709
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James B Rice III was code 93306 (echocardiography (tte/tee)), 932 times for 909 patients. In total James B Rice III billed 4,247 services in 70 codes, and Medicare paid $142K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-07-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93306 Echocardiography (TTE/TEE) | Facility | 932 | 909 | $48.35 | $45K |
| 93010 Electrocardiogram | Facility | 795 | 557 | $5.24 | $4,165 |
| 99214 Office E&M - Established | Facility | 722 | 568 | $63.58 | $46K |
| 36415 Venipuncture Blood Collection | Office | 187 | 137 | $8.65 | $1,618 |
| 93320 Echocardiography (TTE/TEE) | Facility | 160 | 140 | $12.66 | $2,026 |
| 93325 Echocardiography (TTE/TEE) | Facility | 159 | 139 | $2.22 | $354 |
| 93312 Echocardiography (TTE/TEE) | Facility | 142 | 122 | $76.12 | $11K |
| 99152 Anesthesia | Facility | 120 | 104 | $8.67 | $1,040 |
| 80048 Clinical Chemistry | Office | 113 | 94 | $8.29 | $937 |
| 99213 Office E&M - Established | Facility | 99 | 93 | $36.87 | $3,650 |
| 93308 Echocardiography (TTE/TEE) | Facility | 82 | 77 | $17.87 | $1,466 |
| 78452 Myocardial Perfusion Scan | Facility | 80 | 80 | $51.34 | $4,107 |
| 80061 Clinical Chemistry | Office | 62 | 59 | $13.12 | $813 |
| 84460 Clinical Chemistry | Office | 54 | 54 | $5.19 | $280 |
| 84450 Clinical Chemistry | Office | 54 | 54 | $5.08 | $274 |
By year: 2022 $175K for 4,726 services; 2023 $164K for 4,797 services; 2024 $142K for 4,247 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 187 | 137 | $8.65 | $1,618 |
| 80048 Clinical Chemistry | 113 | 94 | $8.29 | $937 |
| 80061 Clinical Chemistry | 62 | 59 | $13.12 | $813 |
| 84450 Clinical Chemistry | 54 | 54 | $5.08 | $274 |
| 84460 Clinical Chemistry | 54 | 54 | $5.19 | $280 |
| 85027 Blood Count | 42 | 40 | $6.34 | $266 |
| 83735 Clinical Chemistry | 22 | 22 | $6.57 | $145 |
| 84443 Clinical Chemistry | 19 | 19 | $16.46 | $313 |
Medicare prescription drug claims, 2024
In 2024, the drug James B Rice III prescribed most often to Medicare patients was Metoprolol Succinate, with 1,707 prescriptions and refills. In total James B Rice III wrote 22,395 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,707 | 3,978 | 485 | $18K |
| Eliquis Apixaban | 1,617 | 2,452 | 316 | $1.4M |
| Amlodipine Besylate Generic | 1,539 | 3,817 | 463 | $6,793 |
| Carvedilol Generic | 1,265 | 3,040 | 352 | $7,659 |
| Rosuvastatin Calcium Generic | 1,193 | 3,007 | 336 | $13K |
| Atorvastatin Calcium Generic | 1,162 | 3,009 | 342 | $7,606 |
| Metoprolol Tartrate Generic | 1,085 | 2,606 | 343 | $6,262 |
| Losartan Potassium Generic | 1,002 | 2,524 | 291 | $8,081 |
| Furosemide Generic | 993 | 2,180 | 299 | $3,376 |
| Lisinopril Generic | 878 | 2,119 | 262 | $4,475 |
| Hydralazine Hcl Generic | 848 | 1,909 | 266 | $9,153 |
| Spironolactone Generic | 841 | 1,921 | 261 | $5,003 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 686 | 1,488 | 164 | $5,764 |
| Ezetimibe Generic | 676 | 1,530 | 183 | $9,457 |
| Entresto Sacubitril/Valsartan | 513 | 690 | 113 | $463K |
Brand drugs: 4,069 claims; generic drugs: 18,326 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James B Rice III $1,709 ($1,709 in general payments such as food, travel and fees) from 19 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $327.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 14 | $327 |
| Amgen Inc. AMGN | 18 | $231 |
| Novartis Pharmaceuticals Corporation NVS | 19 | $201 |
| Kestra Medical Technology Services, Inc. | 2 | $182 |
| Abiomed JNJ | 3 | $171 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $122 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $77.22 |
| Merck Sharp & Dohme LLC MRK | 4 | $64.32 |
| Lantheus Medical Imaging, Inc. LNTH | 2 | $45.23 |
| Boston Scientific Corporation BSX | 2 | $44.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.